Authors:
Ochi, T
Yamane-Sugiyama, A
Ohkubo, Y
Sakane, K
Tanaka, H
Citation: T. Ochi et al., The anti-inflammatory effect of FR188582, a highly selective inhibitor of cyclooxygenase-2, with an ulcerogenic sparing effect in rats, JPN J PHARM, 85(2), 2001, pp. 175-182
Authors:
Kuroda, S
Takamura, F
Tenda, Y
Itani, H
Tomishima, Y
Akahane, A
Sakane, K
Citation: S. Kuroda et al., Design, synthesis and biological evaluation of a novel series of potent, orally active adenosine A(1) receptor antagonists with high blood-brain barrier permeability, CHEM PHARM, 49(8), 2001, pp. 988-998
Authors:
Yamamoto, H
Terasawa, T
Nakamura, A
Kawabata, K
Sakane, K
Matsumoto, S
Matsumoto, Y
Tawara, S
Citation: H. Yamamoto et al., Orally active cephalosporins. part 2: Synthesis, structure-activity relationships and oral absorption of cephalosporins having a C-3 pyridyl side chain, BIO MED CH, 8(5), 2000, pp. 1159-1170
Authors:
Yamamoto, H
Terasawa, T
Ohki, A
Shirai, F
Kawabata, K
Sakane, K
Matsumoto, S
Matsumoto, Y
Tawara, S
Citation: H. Yamamoto et al., Orally active cephalosporins: Synthesis, structure-activity relationships and oral absorption of 3-[(E) and (Z)-2-substituted vinyl]-cephalosporins, BIO MED CH, 8(1), 2000, pp. 43-54
Authors:
Kuroda, S
Akahane, A
Itani, H
Nishimura, S
Durkin, K
Tenda, Y
Sakane, K
Citation: S. Kuroda et al., Novel adenosine A(1) receptor antagonists. Synthesis and structure-activity relationships of a novel series of 3-(2-cyclohexenyl-3-oxo-2,3-dihydropyridazin-6-yl)-2-phenylpyrazolo[1,5-alpha]pyridines, BIO MED CH, 8(1), 2000, pp. 55-64
Authors:
Tawara, S
Ikeda, F
Maki, K
Morishita, Y
Otomo, K
Teratani, N
Goto, T
Tomishima, M
Ohki, H
Yamada, A
Kawabata, K
Takasugi, H
Sakane, K
Tanaka, H
Matsumo, F
Kuwahara, S
Citation: S. Tawara et al., In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi, ANTIM AG CH, 44(1), 2000, pp. 57-62
Authors:
Katsura, Y
Tomishi, T
Inoue, Y
Sakane, K
Matsumoto, Y
Morinaga, C
Ishikawa, H
Takasugi, H
Citation: Y. Katsura et al., Anti-Helicobacter pylori agents. 4. 2-(Substituted guanidino)-4-phenylthiazoles and some structurally rigid derivatives, J MED CHEM, 43(17), 2000, pp. 3315-3321
Authors:
Kuroda, S
Akahane, A
Itani, H
Nishimura, S
Durkin, K
Kinoshita, T
Tenda, Y
Sakane, K
Citation: S. Kuroda et al., Discovery of FR166124, a novel water-soluble pyrazolo-[1,5-a]pyridine adenosine A(1) receptor antagonist, BIOORG MED, 9(14), 1999, pp. 1979-1984
Authors:
Kuroda, S
Akahane, A
Itani, H
Nishimura, S
Durkin, K
Kinoshita, T
Nakanishi, I
Sakane, K
Citation: S. Kuroda et al., Synthesis of the water-soluble adenosine A(1) receptor antagonist FR166124through a novel sequential Horner-Emmons/isomerization reaction, TETRAHEDRON, 55(34), 1999, pp. 10351-10364
Authors:
Kishi, K
Ohki, H
Okuda, S
Kawabata, K
Sakane, K
Matsumoto, Y
Matsumoto, S
Tawara, S
Citation: K. Kishi et al., Synthesis and biological properties of a novel cephalosporin FR86521 having potent activity against methicillin-resistant Staphylococcus aureus (MRSA), J ANTIBIOT, 52(12), 1999, pp. 1152-1155
Citation: T. Nagase et al., Electrical properties of polycrystalline lithium chloroboracite prepared by the sol-gel method, J SOL-GEL S, 13(1-3), 1998, pp. 223-227